![Nessim Torabi-Pour](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Nessim Torabi-Pour
Chief Tech/Sci/R&D Officer at SiSaf Ltd.
Nessim Torabi-Pour active positions
Companies | Position | Start | End |
---|---|---|---|
SiSaf Ltd.
![]() SiSaf Ltd. BiotechnologyHealth Technology SiSaf Ltd. engages in the design and formulation of drugs for topical delivery systems. Its proprietary technology represents a highly effective, non-irritant carrier for cosmetic and medical products, where improved skin penetration, targeting, and controlled release are required. The firm uses nanosilicon as a carrier for active compounds allowing them to penetrate deep beneath the skin's epidermal barrier for controlled release. It operates through its offices located in Belfast and San Jose. The company was founded by Suzanne Roghieh Saffie-Siebert and Timothy John Brundle in 2006 and is headquartered in Belfast, the United Kingdom. | Chief Tech/Sci/R&D Officer | - | - |
Career history of Nessim Torabi-Pour
Former positions of Nessim Torabi-Pour
Companies | Position | Start | End |
---|---|---|---|
pSiMedica Ltd.
![]() pSiMedica Ltd. Miscellaneous Commercial ServicesCommercial Services Part of EyePoint Pharmaceuticals, Inc., pSiMedica Ltd. is a British company that researches and develops nanostructured porous silicon. The company is based in Malvern, UK. The company was founded by Sam di Giacomo. The CEO is Roger Aston. pSiMedica was acquired by EyePoint Pharmaceuticals, Inc. on August 05, 2004 for $40.97 million. | Corporate Officer/Principal | - | - |
Training of Nessim Torabi-Pour
University of London | Doctorate Degree |
King's College London | Graduate Degree |
Statistics
International
United Kingdom | 5 |
Operational
Chief Tech/Sci/R&D Officer | 1 |
Corporate Officer/Principal | 1 |
Doctorate Degree | 1 |
Sectoral
Consumer Services | 3 |
Health Technology | 2 |
Commercial Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Private companies | 2 |
---|---|
SiSaf Ltd.
![]() SiSaf Ltd. BiotechnologyHealth Technology SiSaf Ltd. engages in the design and formulation of drugs for topical delivery systems. Its proprietary technology represents a highly effective, non-irritant carrier for cosmetic and medical products, where improved skin penetration, targeting, and controlled release are required. The firm uses nanosilicon as a carrier for active compounds allowing them to penetrate deep beneath the skin's epidermal barrier for controlled release. It operates through its offices located in Belfast and San Jose. The company was founded by Suzanne Roghieh Saffie-Siebert and Timothy John Brundle in 2006 and is headquartered in Belfast, the United Kingdom. | Health Technology |
pSiMedica Ltd.
![]() pSiMedica Ltd. Miscellaneous Commercial ServicesCommercial Services Part of EyePoint Pharmaceuticals, Inc., pSiMedica Ltd. is a British company that researches and develops nanostructured porous silicon. The company is based in Malvern, UK. The company was founded by Sam di Giacomo. The CEO is Roger Aston. pSiMedica was acquired by EyePoint Pharmaceuticals, Inc. on August 05, 2004 for $40.97 million. | Commercial Services |
- Stock Market
- Insiders
- Nessim Torabi-Pour
- Experience